4,222
Views
5
CrossRef citations to date
0
Altmetric
Pulmonary Medicine

COVID-19-related end stage lung disease: two distinct phenotypes

, ORCID Icon, &
Pages 588-590 | Received 08 Nov 2021, Accepted 04 Feb 2022, Published online: 16 Feb 2022

References

  • King CS, Mannem H, Kukreja J, et al. Lung transplantation of COVID-19 patients: how I do it. Chest. 2022;161(1):169–178.
  • Joob B, Wiwanitkit V. Pulmonary pathology of early phase 2019 novel coronavirus pneumonia. J Thorac Oncol. 2020; 15(5):e67.
  • John AE, Joseph C, Jenkins G, et al. COVID-19 and pulmonary fibrosis: a potential role for lung epithelial cells and fibroblasts. Immunol Rev. 2021; 302(1):228–240.
  • Guler SA, Ebner L, Aubry-Beigelman C, et al. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J. 2021; 57(4):2003690.
  • Ambardar SR, Hightower SL, Huprikar NA, et al. Post-COVID-19 pulmonary fibrosis: novel sequelae of the current pandemic. J Clin Med. 2021;(11):10.
  • Leung J, Cho Y, Lockey RF, et al. The role of aging in idiopathic pulmonary fibrosis. Lung. 2015; 193(4):605–610.
  • Combet M, Pavot A, Savale L, et al. Rapid onset honeycombing fibrosis in spontaneously breathing patient with COVID-19. Eur Respir J. 2020; 56(2):2001808.
  • Sheng G, Chen P, Wei Y, et al. Viral infection increases the risk of idiopathic pulmonary fibrosis: a meta-analysis. Chest. 2020; 157(5):1175–1187.
  • Han X, Fan Y, Alwalid O, et al. Fibrotic interstitial lung abnormalities at 1-year follow-up CT after severe COVID-19. Radiology. 2021; 301(3):E438–E440.